| Title: |
Anthranilic amide and imidazobenzothiadiazole compounds disrupt Mycobacterium tuberculosismembrane potential |
| Authors: |
Smith, Jake; Wescott, Heather; Early, Julie; Mullen, Steven; Guzman, Junitta; Odingo, Joshua; Lamar, Jason; Parish, Tanya |
| Contributors: |
Eli Lilly and Company; Bill and Melinda Gates Foundation |
| Source: |
MedChemComm ; volume 10, issue 6, page 934-945 ; ISSN 2040-2503 2040-2511 |
| Publisher Information: |
Royal Society of Chemistry (RSC) |
| Publication Year: |
2019 |
| Description: |
Compounds 1 and 2 disrupt M. tuberculosis membrane potential and demonstrate bactericidal activity against non-replicating M. tuberculosis in pH 4.5 buffer. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1039/c9md00088g |
| Availability: |
https://doi.org/10.1039/c9md00088g; http://pubs.rsc.org/en/content/articlepdf/2019/MD/C9MD00088G |
| Rights: |
http://creativecommons.org/licenses/by/3.0/ |
| Accession Number: |
edsbas.BA7CF4D1 |
| Database: |
BASE |